Abilify is a brand-name oral tablet that doctors prescribe for certain mental health disorders, such as schizophrenia. There may be other conditions, such as anxiety, where doctors may use Abilify off ...

May 24, 2007 (San Diego) — A recent study found that among patients in a psychiatric hospital, the atypical antipsychotic quetiapine (Seroquel, AstraZeneca), which is approved for schizophrenia and ...

Researchers from the University of California San Diego found that prescriptions for leucovorin, a drug sometimes used ...

A new study finds that off-label drug use is associated with higher rates of adverse drug events in adults. Off-label use of prescription drugs is known to be associated with adverse drug events (ADEs ...

Although eculizumab is only approved by the FDA to treat 3 rare indications, the high and increasing net sales for the drug have raised concerns about off-label use, according to a research letter in ...

One of the most alarming things about COVID-19 is that there are no FDA-approved drugs to fight it. Instead, doctors have turned to medications such as azithromycin, chloroquine, hydroxychloroquine, ...

Topamax (topiramate) is not FDA-approved for weight loss, but doctors may prescribe the drug off-label. Or they may recommend Qsymia, which is an FDA-approved weight loss drug that also contains ...

Explore the potential benefits and risks of using type 2 diabetes drugs like Ozempic and metformin off-label to manage weight ...

Ativan (lorazepam) is a brand-name drug that your doctor may prescribe off-label for alcohol withdrawal. The drug isn’t approved for this use, but it has been shown to be helpful in treating alcohol ...

With a look at 160 common medications, about one out of every five are prescribed off-label, according to recent research. This means that the drugs were used in ways never approved by the FDA.

Impact of Circulating Tumor DNA–Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors Among 46,712 patients who received targeted therapies, we ...